Current Issue

June 2018 | Volume 17 | Issue 6

Who Is Accountable When Patients Do Not Achieve Successful Treatment for Their Acne?

ABSTRACT: Acne vulgaris (AV) is a very common inflammatory facial disorder that is complex in its pathophysiology, heterogenous in clinical presentation, and affects children and adults of all ethnicities, races, and skin types. more

Currently Constrained, Dermatologists Are Ready for New Acne Therapies

ABSTRACT: Acne is the most common skin condition in the United States, affecting 50 million Americans annually. The disease’s severity can range from mild to severe, with approximately 20% of people with acne experiencing moderate to severe disease. more

Beyond Traditional Treatment: The Importance of Psychosocial Therapy in Vitiligo

ABSTRACT: Vitiligo is an acquired depigmentation disorder of the skin. Patients with vitiligo often face a challenging disease course, having to cope with a condition that is known to be physically disfiguring, psychologically devastating, and socially stigmatizing. Although an extensive amount of research has been directed towards the dermatologic treatment of vitiligo, an overall lack of data exists investigating treatment of the psychological and emotional burden of patients with vitiligo. This paper reviews the literature for treatment options in patients with vitiligo that specifically target the psychosocial domain. Despite being limited in quantity, several studies have proven the benefits of adjuvant care in the form of group therapy, cognitive behavioral therapy, and self-help programs. Although preliminary evidence is promising, larger prospective studies are needed to further define the role of these psychosocial interventions before integrating them in a more official capacity into the standard of care for patients with vitiligo. Because of the considerable impact of vitiligo beyond its physical symptoms, dermatologists ought to consider the utility of adjuvant therapies to adequately address impairments in self-esteem, body image, and quality of life in patients with vitiligo. J Drugs Dermatol. 2018;17(6):688-691. more

Articles are encrypted; any PDFs printed from this website will include a JDD copyright protection watermark.